Suppr超能文献

寒冷促进活化以及因子 XII、前激肽释放酶和 C1 抑制剂。

Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.

作者信息

Czendlik C, Lämmle B, Duckert F

出版信息

Thromb Haemost. 1985 Apr 22;53(2):242-4.

PMID:2410997
Abstract

During incubation of plasma in the cold an amidolytic activity due to the kallikrein-alpha 2-macroglobulin complex appears in the plasma of about 40% of the women under hormonal contraception. The factor XII and prekallikrein activity are significantly increased 151.9% and 112.4% respectively in the cold promoted activation positive plasmas (CPA pos) whereas the activity of C1-inhibitor is decreased, 76%. The quotient of the product of the C1-inhibitor and alpha 2-macroglobulin values divided by the product of the FXII and prekallikrein values is significantly lower in the CPA pos plasma 0.49 than in CPA neg plasma 0.96 (p less than 0.05). These results alone do not explain the cold promoted activation, since a patient with a C1-inhibitor as low as 9% showed no increase of the amidolytic activity after a 24 hr incubation at 4 degrees C. However, the addition of purified C1-inhibitor to a CPA pos. plasma inhibits the cold activation. Heparin at a concentration of 0.5 IU/ml delays the appearance of the amidolytic activity.

摘要

在低温下孵育血浆时,约40%接受激素避孕的女性血浆中会出现因激肽释放酶-α2-巨球蛋白复合物导致的酰胺水解活性。在冷促进激活阳性血浆(CPA pos)中,因子XII和前激肽释放酶活性分别显著增加151.9%和112.4%,而C1抑制剂的活性降低了76%。CPA pos血浆中C1抑制剂与α2-巨球蛋白值的乘积除以FXII与前激肽释放酶值的乘积的商为0.49,显著低于CPA neg血浆中的0.96(p<0.05)。仅这些结果并不能解释冷促进激活现象,因为一名C1抑制剂低至9%的患者在4℃孵育24小时后酰胺水解活性并未增加。然而,向CPA pos血浆中添加纯化的C1抑制剂可抑制冷激活。浓度为0.5 IU/ml的肝素会延迟酰胺水解活性的出现。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验